These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9639449)

  • 21. Fluorescein angiography of the fundus in diabetic retinopathy.
    Kohner EM; Dollery CT
    Br Med Bull; 1970 May; 26(2):166-70. PubMed ID: 4911770
    [No Abstract]   [Full Text] [Related]  

  • 22. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509.
    Robinson WG; Laver NM; Jacot JL; Glover JP; Basso MD; Blouin P; Hohman TC
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1149-56. PubMed ID: 8631629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Mar; 114(3):306-10. PubMed ID: 8600891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Grading of diabetic retinopathy from non-stereoscopic color fundus photographs--relationship to fluorescein angiography findings and three-year prognosis].
    Kitano S
    Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):563-72. PubMed ID: 16218434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.
    van Gerven JM; Boot JP; Lemkes HH; van Best JA
    Doc Ophthalmol; 1992; 80(2):183-8. PubMed ID: 1425133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aqueous flow in galactose-fed dogs.
    Toris CB; Lane JT; Akagi Y; Blessing KA; Kador PF
    Exp Eye Res; 2006 Oct; 83(4):865-70. PubMed ID: 16797006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two years' fluorescein follow-up of diabetic microaneurysms.
    Ferrer O
    Trans Ophthalmol Soc U K (1962); 1966; 86():497-506. PubMed ID: 5226592
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin-like growth factor-1 retinal microangiopathy in the pig eye.
    Danis RP; Bingaman DP
    Ophthalmology; 1997 Oct; 104(10):1661-9. PubMed ID: 9331208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental galactosemia produces diabetic-like retinopathy.
    Engerman RL; Kern TS
    Diabetes; 1984 Jan; 33(1):97-100. PubMed ID: 6360771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperglycemia as a cause of diabetic retinopathy.
    Engerman RL; Kern TS
    Metabolism; 1986 Apr; 35(4 Suppl 1):20-3. PubMed ID: 3083205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mouse model of diabetic retinopathy.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Aug; 114(8):986-90. PubMed ID: 8694735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP; Jacot JL; Basso MD; Hohman TC; Robison WG
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indocyanine green angiographic findings in nonproliferative diabetic retinopathy.
    Weinberger D; Kramer M; Priel E; Gaton DD; Axer-Siegel R; Yassur Y
    Am J Ophthalmol; 1998 Aug; 126(2):238-47. PubMed ID: 9727518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.
    Tolentino MJ; McLeod DS; Taomoto M; Otsuji T; Adamis AP; Lutty GA
    Am J Ophthalmol; 2002 Mar; 133(3):373-85. PubMed ID: 11860975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophils in galactose-fed dogs: suppressed apoptosis and increased adhesion to retinal capillary endothelial cells.
    Ohta N; Tsai JY; Secchi EF; Kador PF; Sato S
    J Diabetes Complications; 1999; 13(3):151-8. PubMed ID: 10509875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats.
    Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
    J Ocul Pharmacol Ther; 1995; 11(3):469-87. PubMed ID: 8590278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.